Daniil Gataulin
Stock Analyst at Chardan Capital
(4.89)
# 46
Out of 5,114 analysts
114
Total ratings
69.52%
Success rate
43.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $12.56 | +67.20% | 4 | Dec 9, 2025 | |
| QURE uniQure | Maintains: Buy | $53 | $23.99 | +120.93% | 11 | Dec 4, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $14.59 | +256.41% | 14 | Nov 20, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $29.69 | +105.46% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $26.00 | -46.15% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $4.27 | +134.19% | 3 | Nov 14, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.03 | +335.87% | 7 | Nov 14, 2025 | |
| IRD Opus Genetics | Maintains: Buy | $9 | $2.00 | +350.00% | 3 | Nov 13, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $51 | $21.25 | +140.00% | 9 | Nov 11, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.40 | +400.00% | 14 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $2.01 | +49.25% | 10 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $7.60 | +97.37% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.54 | +159.74% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $17.43 | +54.91% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.71 | +30,995.41% | 1 | Mar 7, 2024 |
Ocular Therapeutix
Dec 9, 2025
Maintains: Buy
Price Target: $21
Current: $12.56
Upside: +67.20%
uniQure
Dec 4, 2025
Maintains: Buy
Price Target: $53
Current: $23.99
Upside: +120.93%
REGENXBIO
Nov 20, 2025
Maintains: Buy
Price Target: $52
Current: $14.59
Upside: +256.41%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $29.69
Upside: +105.46%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $26.00
Upside: -46.15%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $4.27
Upside: +134.19%
MeiraGTx Holdings
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $8.03
Upside: +335.87%
Opus Genetics
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $2.00
Upside: +350.00%
Oculis Holding AG
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $21.25
Upside: +140.00%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.40
Upside: +400.00%
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $2.01
Upside: +49.25%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $7.60
Upside: +97.37%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.54
Upside: +159.74%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $17.43
Upside: +54.91%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.71
Upside: +30,995.41%